Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FD07T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,069
Award facts
- Contract value 100% obligated
- $15,069.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of RINVOQ ER 15 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $15,069.18, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle that extends through December 2026. The contract utilizes a standard delivery order mechanism with a completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
RINVOQ (upadacitinib) is a selective JAK inhibitor used in the treatment of rheumatoid arthritis and other autoimmune conditions, reflecting the Defense Health Agency's ongoing need for specialty pharmaceutical support across military healthcare systems. This award is one of numerous delivery orders AmerisourceBergen fulfills under its prime IDV with DLA, which enables the company to supply a comprehensive range of pharmaceutical products, including specialty medications, vaccines, and medical supplies to support military personnel and veterans. The non-set-aside designation confirms this award was competitively available under the existing contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FD07T?
SPE2DB25FD07T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FD07T worth?
The government has obligated $15,069 on SPE2DB25FD07T.
Is contract SPE2DB25FD07T an order under another contract?
Yes. SPE2DB25FD07T is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FD07T competed?
The extent of competition for SPE2DB25FD07T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award